S2k‐Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen – Kurzfassung Teil 1

Eisert, Lisa; Augustin, Matthias; Bach, Sabine; Dittmann, M.; Eiler, Renate; Fölster‐Holst, Regina; Gerdes, Sascha; Hamm, Henning; Höger, P.; Horneff, Gerd; Kiedrowski, Ralph von; Philipp, Sandra; Pleimes, Marc; Schlaeger, Martin; Schuster, Volker; Staubach, Petra; Weberschock, Tobias; Werner, Ricardo Niklas; Nast, Alexander; Sticherling, Michael

doi:10.1111/ddg.13907_g

Cited by 4 publications

(6 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…• Second most common type; accounts for 22.2% of cases in infants with psoriasis 25 • Causes lesions in the skin folds (in the armpits and groin) more often than in adults and in the anogenital area because of particular rubbing 10 Erythrodermic psoriasis…”

Section: Plaque Psoriasismentioning

confidence: 99%

“…• Occurs in approximately 40% of children with severe psoriasis 25 • Less common in children than in adults 25 • Characterized by yellow subungual plaques (oil spots) and pitting in the nail plate 10 Scalp psoriasis…”

Section: Facial Psoriasismentioning

confidence: 99%

“…• Accounts for 15%-30% of cases of pediatric psoriasis 10,25 • More common in children than in adults 27 • Characterized by the rapid onset of guttate papular lesions associated with infection 10,25 Diaper psoriasis…”

Section: Plaque Psoriasismentioning

confidence: 99%

“…However, there is insufficient evidence regarding the medical treatment of pediatric psoriasis and no internationally harmonized guidelines have been developed to date 8 . National guidelines for the treatment of pediatric psoriasis include the 2019 Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients, 9 the 2019 guidelines for the treatment of psoriasis in children and adolescents, jointly prepared by German dermatologists, pediatric dermatologists, and pediatric rheumatologists, 10,11 and the 2022 consensus on the management of pediatric psoriasis prepared by Italian dermatologists 12 . In Japan, guidelines for psoriasis include the 2014 guidelines for the management and treatment of generalized pustular psoriasis (GPP), 13 the 2019 guidelines for the treatment of psoriatic arthritis (PsA), 14 the 2016 guidelines for phototherapy in psoriasis, 15 and the 2022 guidance for the use of biologics for psoriasis 16 .…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Pediatric psoriasis: Understanding pathological conditions and advances in treatment

Morita,

Saeki

2023

The Journal of Dermatology

View full text Add to dashboard Cite

Psoriasis is a long‐lasting skin disease that primarily affects the skin, nails, and joints and is characterized by inflammation. Genetic factors contribute to its development and environmental triggers can worsen symptoms. Pathologically, psoriasis is characterized by uncontrolled keratinocyte proliferation and abnormal differentiation, and histological features include acanthosis with inflammatory cell infiltration and neovascularization. Psoriasis often starts in childhood, with about one‐third of cases beginning during this time. Its prevalence steadily increases from the ages of 1 to 18 years in a linear fashion. Young people with psoriasis often require treatment throughout their childhood and adolescence, and into adulthood. However, prolonged treatment may increase the risk of complications and adverse events, so it is important to adopt an effective treatment approach that minimizes this risk. In addition, psoriasis is often associated with various comorbidities that may place a great burden on the physical and mental health of the children beyond those due to psoriasis itself. To ensure good long‐term health outcomes, individuals with psoriasis should undergo regular screening. Treatment should be provided not only for skin lesions, but also for any comorbidities; however, currently there is not enough evidence on the treatment of pediatric psoriasis and no globally agreed‐on guidelines exist for treating psoriasis in children. This article describes the etiology, clinical symptoms, and disease burden of pediatric psoriasis, the pathological conditions and diagnosis of plaque psoriasis, psoriatic arthritis, and generalized pustular psoriasis, and the available treatments for these conditions in Japan.

show abstract

Section: Plaque Psoriasismentioning

confidence: 99%

Section: Facial Psoriasismentioning

confidence: 99%

Section: Plaque Psoriasismentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Pediatric psoriasis: Understanding pathological conditions and advances in treatment

Morita,

Saeki

2023

The Journal of Dermatology

View full text Add to dashboard Cite

show abstract

“…(Mod. nach Eisert et al [5]) werden an unserer Klinik Kontrollen in 3-monatigen Abständen durchgeführt.…”

Section: Uv-b-schmalspektrumunclassified

Ungewöhnliche Präsentation einer Psoriasis vulgaris bei einem 11-jährigen Patienten

et al. 2022

View full text Add to dashboard Cite

ZusammenfassungDie Psoriasis vulgaris tritt mit einer Prävalenz von bis zu 2 % im Kindes- und Jugendalter auf. Größtenteils wird die Diagnose klinisch gestellt. Wir berichten über einen pädiatrischen Patienten, welcher uns aufgrund der für eine Psoriasis vulgaris eher untypischen Lokalisation vor eine diagnostische Herausforderung stellte. Diskutiert werden die wichtigsten Differenzialdiagnosen der verschiedenen Psoriasisformen sowie die aktuellen Therapieempfehlungen im Kindes- und Jugendalter.

show abstract

Update on the Management of Pediatric Psoriasis: An Italian Consensus

Peris

Fortina

Bianchi

et al. 2022

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

Introduction: Psoriasis affects children with a considerable burden in early life. Treating pediatric psoriasis is challenging also because of the lack of updated specific guidelines. With the recent approval of several biologics for pediatric psoriasis and the ongoing COVID-19 pandemic, the management of young psoriatic patients is facing major changes. A revision of treatment recommendations is therefore needed.

show abstract

S2k‐Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen – Kurzfassung Teil 1

Cited by 4 publications

References 60 publications

Pediatric psoriasis: Understanding pathological conditions and advances in treatment

Pediatric psoriasis: Understanding pathological conditions and advances in treatment

Ungewöhnliche Präsentation einer Psoriasis vulgaris bei einem 11-jährigen Patienten

Update on the Management of Pediatric Psoriasis: An Italian Consensus

Contact Info

Product

Resources

About